Liu Z D, Khodr H H, Lu S L, Hider R C
Department of Pharmacy, King's College London, UK.
J Pharm Pharmacol. 2000 Mar;52(3):263-72. doi: 10.1211/0022357001773940.
To investigate the possibility of targeting chelators into the lysosomal iron pool, nine bidentate 3-hydroxypyridin-4-ones with basic chains have been synthesized. As the turnover of ferritin iron is centred in the lysosome, such strategy is predicted to increase chelator efficacy of bidentate ligands. The pKa values of the ligands together with their distribution coefficients between 1-octanol and 4-morpholinepropane sulphonic acid (MOPS) buffer pH 7.4 have been determined. The in-vivo iron mobilization efficacy of these basic 3-hydroxypyridin-4-ones has been investigated in a 59Fe-ferritin-loaded rat model. No obvious correlation was observed between efficacy and the pKa value of the side chain, although those with pKa > 7.0 tended to be more efficient than those with pKa < 7.0. The imidazole-containing molecules are much less effective than the tertiary amine derivatives. A dose-response study suggested that basic pyridinones are relatively more effective at lower doses when compared with N-alkyl hydroxypyridinones. Optimal effects were observed with the piperidine derivatives 4h and 4i. The derivative 4i at a dose of 150 micromol kg(-1) was more effective than 450 micromol kg(-1) deferiprone, the widely adopted clinical dose.
为了研究将螯合剂靶向溶酶体铁池的可能性,已合成了9种带有碱性链的双齿3-羟基吡啶-4-酮。由于铁蛋白铁的周转集中在溶酶体中,预计这种策略会提高双齿配体的螯合剂功效。已测定了这些配体的pKa值及其在1-辛醇和pH 7.4的4-吗啉丙烷磺酸(MOPS)缓冲液之间的分配系数。在59Fe-铁蛋白负载的大鼠模型中研究了这些碱性3-羟基吡啶-4-酮的体内铁动员功效。虽然pKa> 7.0的那些往往比pKa <7.0的更有效,但未观察到功效与侧链pKa值之间有明显相关性。含咪唑的分子比叔胺衍生物的效果要差得多。剂量反应研究表明,与N-烷基羟基吡啶酮相比,碱性吡啶酮在较低剂量时相对更有效。哌啶衍生物4h和4i观察到了最佳效果。剂量为150 μmol kg(-1)的衍生物4i比广泛采用的临床剂量450 μmol kg(-1)的去铁酮更有效。